Condensed Consolidated Statements of Operations - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2023	Dec. 31, 2022
Income Statement [Abstract]
Net sales	$ 254,143	$ 230,370	$ 748,036	$ 682,397
Cost of products sold	160,246	148,326	467,513	431,516
Gross profit	93,897	82,044	280,523	250,881
Selling expenses	26,552	25,424	78,400	77,197
General and administrative expenses	26,255	25,143	79,407	68,441
Research and development expenses	6,692	4,839	19,134	15,429
Amortization of intangibles	7,486	6,459	21,871	19,442
Operating expenses	66,985	61,865	198,812	180,509
Income from operations	26,912	20,179	81,711	70,372
Interest and debt expense	9,952	7,303	28,788	20,274
Investment (income) loss	(758)	(574)	(1,212)	168
Foreign currency exchange (gain) loss	(1,155)	(3,359)	1,074	(1,152)
Other (income) expense, net	5,234	79	5,840	(1,999)
Income (loss) before income tax expense (benefit)	13,639	16,730	47,221	53,081
Income tax expense (benefit)	3,911	4,701	12,405	18,547
Net income (loss)	$ 9,728	$ 12,029	$ 34,816	$ 34,534
Average basic shares outstanding (in shares)	28,744	28,626	28,711	28,597
Average diluted shares outstanding (in shares)	28,991	28,778	28,979	28,767
Basic income (loss) per share (in dollars per share)	$ 0.34	$ 0.42	$ 1.21	$ 1.21
Diluted income (loss) per share (in dollars per share)	0.34	0.42	1.20	1.20
Dividends declared per common share (in dollars per share)	$ 0.07	$ 0.07	$ 0.14	$ 0.14